Equal benefits to our residential courses, without the travel.View Courses
All our courses. 12 months access. One flat fee.More Information
Non-members can signup to keep up to date with RQA news and events.Add your details now
9th February 2022
On 1st January this year, the Health Research Authority (HRA) and the Medicines and Healthcare products Regulatory Agency (MHRA) completed the roll out of their new combined review service for researchers seeking approval for the nearly 1000 Clinical Trials of Investigational Medicinal Products (CTIMPs) reviewed every year.
The launch resulted from the collaborative efforts of the HRA and MHRA to contribute to the UK’s vision for life sciences, in particular building on the strength of the UK as a place to conduct research.
In this joint blog, Catherine Blewett, Senior Development Manager at the HRA, and Martin O’Kane, Head of the MHRA Clinical Trials Unit, fill us in on the new process, which will lead to faster approvals.